字节系AI制药公司首轮融资 谷歌等巨头集体转向AI4S

格隆汇
Sep 17
近日,由字节跳动分拆出来的AI制药公司新生探途(Anew Labs)宣布完成首轮天使轮融资,融资金额2.9亿美元,投后估值达15亿美元。融资完成后,字节跳动保留56%股份,保持控股地位。据悉,新生探途前身为字节跳动内部药物发现团队,由AI4S算法人才和资深制药领域专家构成,2021年由刘凯牵头组建,核心团队约50人。2026年6月,上述业务从字节跳动分拆独立运营后,核心团队整体迁入新主体。 依托AI4S入局新药研发赛道,早已成为众巨头布局的重要方向。Anthropic首席执行官Dario Amodei曾直言,生命科学属于公司战略优先级最高的领域之一,目前正与诺和诺德合作利用AI工具推进药物研发。谷歌旗下Isomorphic Labs在今年5月完成21亿美元B轮融资,其一方面同药企开展合作研发,另一方面自主持有并推进多条新药管线。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10